Bendamustini hydrochloridum
| Medicinal product name | Bendamustine Accord 2.5 mg/ml powder for concentrate for solution for infusion |
|---|---|
| Pharmaceutical form | Powder for concentrate for solution for infusion |
| Strength | 2.5 mg/ml |
| Information from the MAH on shortages | No information on expected shortages |
| Legal status | Prescription (Pr.) |
| Package leaflet |  02-08-2022
|
| Summary of product characteristics | 04-02-2021
|
| ATC code | L01AA09 – Antineoplastic agents |
Medicinal products (5)
| Availability of medicinal product | Wholesalers | Package size, content | Primary packaging | Maximum admissible pharmacy price (€ incl. VAT) | Product No. | Labelling |
|---|---|---|---|---|---|---|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N5 (25 mg) |
Glass vial | 16-0004-01 |
Labelling text Oct 29, 2020 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N10 (25 mg) |
Glass vial | 16-0004-02 |
Labelling text Oct 29, 2020 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N20 (25 mg) |
Glass vial | 16-0004-03 |
Labelling text Oct 29, 2020 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N1 (100 mg) |
Glass vial | 16-0004-04 |
Labelling text Oct 29, 2020 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N5 (100 mg) |
Glass vial | € 715.78 | 16-0004-05 |
Labelling text Oct 29, 2020 |
Registration information
| Marketing authorisation No. | 16-0004 |
|---|---|
| Date of authorisation | Jan 13, 2016 |
| Marketing authorisation holder, country | Accord Healthcare B.V., Netherlands |
